Please login to the form below

Not currently logged in
Email:
Password:

ESUS

This page shows the latest ESUS news and features for those working in and with pharma, biotech and healthcare.

Xarelto no better than aspirin in secondary stroke study

Xarelto no better than aspirin in secondary stroke study

Patients with ESUS currently have limited treatment options and the role of anticoagulants in this area remains uncertain,” said Joerg Moeller, Bayer's head of development. ... We will now analyse the data from NAVIGATE ESUS to better understand this

Latest news

  • Pradaxa cleared for new indications in Europe Pradaxa cleared for new indications in Europe

    Boehringer also hopes to extend Pradaxa's uses into the prevention of recurrent stroke, and recently started a 6, 000-patient study in embolic stroke of undetermined source (ESUS).

  • Boehringer unveils large study in stroke prevention Boehringer unveils large study in stroke prevention

    Specifically, the 6, 000-patient study will look at the safety and efficacy of Pradaxa (dabigatran) in people who have already suffered an embolic stroke of undetermined source (ESUS), in other ... Boehringer announced the new trial - called RE-SPECT

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • NOAC Education: Empowering Stroke Prevention

    Prophylactic anticoagulation is also being explored in conditions such as embolic strokes of undetermined source (ESUS) or when there is a risk of a patient developing venous thromboembolism (VTE).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....